Chantix, Zyban get Black Box warnings from FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Chantix, Zyban get Black Box warnings from FDA

July 2nd, 2009 joshua

The popular and extremely controversial stop-smoking drugs Chantix and Zyban have received the Food and Drug Administration’s most stern warning.

Regulators ruled earlier this week to place its Black Box warning on the labels of all lots of Chantix and Zyban to notify physicians, pharmacists and consumers of their link to severe psychological side effects, including suicidal behavior and thoughts.

Thousands, if not more than a million people have been subscribed Chantix or Zyban to help quit smoking. Off-label applications of the drug were to treat Post Traumatic Stress Disorder.

However, as more people began receiving Chantix, more reports began to surface of aggressive and suicidal behavior in those taking it.

Reports of soldiers being given Chantix upon returning from tours of active duty were also noted, including a military program to use Chantix in such a way, despite it not being approved to treat PTSD.

In mandating the warning, the FDA also wants further study on the drugs to determine the extent of the side effects.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.